FDA looks into cancer concerns related to insulin Lantus

07/2/2009 | Bloomberg

The FDA is examining Sanofi-Aventis' insulin Lantus after reports released last week linked the drug to an increased risk of tumors. The move comes days after diabetes experts urged patients to continue using Lantus despite the possible risk.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC